The Pharmaceuticals in Dosage market size value per capita in the UK showed a varied trend from 2012 to 2022. The market saw an initial increase from $1.28 thousand per capita in 2012 to a peak of $1.64 thousand per capita in 2015. Subsequently, there was a decline, reaching the lowest point at $0.9821 thousand per capita in 2022. Year-on-year, for 2023, the value stood slightly above $0.98 thousand per capita suggesting a stabilization phase. Comparing the last two years, a decrease of 7.54% in 2022 was recorded relative to 2021, and a slight increase of 8% in 2023. Over the last five years, the market shows a CAGR (Compound Annual Growth Rate) of -2.85%, indicating an overall negative growth trend during this period.
Future trends to watch for include potential improvements in pharmaceutical innovations and regulatory advancements, increased integration of personalized medicine which could boost market value, and a deeper focus on digital health solutions and telemedicine. Monitoring these elements will be crucial for anticipating market changes and capitalizing on arising opportunities.
How does the United Kingdom rank in Pharmaceuticals in Dosage Market Size Value Per Capita?
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 7 | 7 Austria | 1,010 | 2023 | View data | ||
| 8 | 8 Israel | 990.06 | 2023 | View data | ||
| 9 | 9 United Kingdom | 969.43 | 2023 | |||
| 10 | 10 Spain | 929.61 | 2023 | View data | ||
| 11 | 11 Canada | 909.67 | 2023 | View data | ||